These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10603661)

  • 21. Haemophilus influenzae infection and Guillain-Barré syndrome.
    Mori M; Kuwabara S; Miyake M; Noda M; Kuroki H; Kanno H; Ogawara K; Hattori T
    Brain; 2000 Oct; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
    Odaka M; Koga M; Yuki N; Susuki K; Hirata K
    J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
    Okuda B; Koga M; Katsuta T; Okamoto K; Yuki N
    Intern Med; 2002 Oct; 41(10):889-91. PubMed ID: 12413017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flagella as a potential marker for Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Tsang RS; Figueroa G; Bryden L; Ng L
    J Clin Microbiol; 2001 Feb; 39(2):762-4. PubMed ID: 11158146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome.
    Mishu B; Ilyas AA; Koski CL; Vriesendorp F; Cook SD; Mithen FA; Blaser MJ
    Ann Intern Med; 1993 Jun; 118(12):947-53. PubMed ID: 8489109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
    Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome.
    Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK; Pradhan S
    Med Microbiol Immunol; 2010 May; 199(2):109-16. PubMed ID: 20157729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isotype, specificity, and kinetics of systemic and mucosal antibodies to Campylobacter jejuni antigens, including flagellin, during experimental oral infections of chickens.
    Cawthraw S; Ayling R; Nuijten P; Wassenaar T; Newell DG
    Avian Dis; 1994; 38(2):341-9. PubMed ID: 7526839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
    Takahashi M; Koga M; Yokoyama K; Yuki N
    J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactive epitopes present in campylobacter jejuni serotypes isolated from enteritis patients.
    Grozdanova A; Poceva-Panovska A; Brezovska K; Trajkovska-Dokic E; Dimovski A; Apostolski S; Suturkova Lj
    Prilozi; 2011; 32(1):113-25. PubMed ID: 21822182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from Greece.
    Chatzipanagiotou S; Kilidireas K; Trimis G; Nicolaou C; Anagnostouli M; Athanassaki C; Giannoulia A; Legakis N; Youroukos S
    Clin Microbiol Infect; 2003 Jan; 9(1):69-72. PubMed ID: 12691547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA; Rees JH; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome.
    Nishimura M; Nukina M; Kuroki S; Obayashi H; Ohta M; Ma JJ; Saida T; Uchiyama T
    J Neurol Sci; 1997 Dec; 153(1):91-9. PubMed ID: 9455985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
    Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
    No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal study of serum and cerebrospinal fluid (CSF) class-specific antibodies against Campylobacter jejuni and GM1 ganglioside in Guillain-Barré syndrome.
    Kimura F; Ito T; Yuki N; Nakajima H; Tanaka T; Shinoda K; Ohsawa N
    Intern Med; 1995 Oct; 34(10):1009-14. PubMed ID: 8563080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.